CYP1B1 and breast cancer: Mechanistically, FOXO1-regulated CYP1B1-AS1 affected the heterodimeric enzyme NAE by directly binding to NAE1 to regulate protein neddylation, thereby inhibiting the malignant progression of breast cancer (Fig. 6i).